Literature DB >> 25733505

Third-generation-cephalosporin-resistant Klebsiella pneumoniae isolates from humans and companion animals in Switzerland: spread of a DHA-producing sequence type 11 clone in a veterinary setting.

Nadia Wohlwend1, Andrea Endimiani2, Thierry Francey3, Vincent Perreten4.   

Abstract

Characterization of third-generation-cephalosporin-resistant Klebsiella pneumoniae isolates originating mainly from one human hospital (n = 22) and one companion animal hospital (n = 25) in Bern (Switzerland) revealed the absence of epidemiological links between human and animal isolates. Human infections were not associated with the spread of any specific clone, while the majority of animal infections were due to K. pneumoniae sequence type 11 isolates producing plasmidic DHA AmpC. This clonal dissemination within the veterinary hospital emphasizes the need for effective infection control practices.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25733505      PMCID： PMC4394820          DOI： 10.1128/AAC.04408-14

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  20 in total

1.  Complete nucleotide sequence of pK245, a 98-kilobase plasmid conferring quinolone resistance and extended-spectrum-beta-lactamase activity in a clinical Klebsiella pneumoniae isolate.

Authors:  Ying-Tsong Chen; Hung-Yu Shu; Ling-Hui Li; Tsai-Lien Liao; Keh-Ming Wu; Yih-Ru Shiau; Jing-Jou Yan; Ih-Jen Su; Shih-Feng Tsai; Tsai-Ling Lauderdale
Journal:  Antimicrob Agents Chemother       Date:  2006-08-28       Impact factor: 5.191

2.  Selection of CMY-2 producing Escherichia coli in the faecal flora of dogs treated with cephalexin.

Authors:  Peter Damborg; Ingrid B Gaustad; John E Olsen; Luca Guardabassi
Journal:  Vet Microbiol       Date:  2011-03-21       Impact factor: 3.293

3.  Evaluation of an expanded microarray for detecting antibiotic resistance genes in a broad range of gram-negative bacterial pathogens.

Authors:  Roderick Card; Jiancheng Zhang; Priya Das; Charlotte Cook; Neil Woodford; Muna F Anjum
Journal:  Antimicrob Agents Chemother       Date:  2012-11-05       Impact factor: 5.191

4.  Emergence of OXA-48 carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in dogs.

Authors:  Inka Stolle; Ellen Prenger-Berninghoff; Ivonne Stamm; Sandra Scheufen; Esther Hassdenteufel; Sebastian Guenther; Astrid Bethe; Yvonne Pfeifer; Christa Ewers
Journal:  J Antimicrob Chemother       Date:  2013-07-05       Impact factor: 5.790

5.  Physical and genetic analysis of the ColD plasmid.

Authors:  J Frey; P Ghersa; P G Palacios; M Belet
Journal:  J Bacteriol       Date:  1986-04       Impact factor: 3.490

6.  Surveillance of extended-spectrum beta-lactamase-producing bacteria and routine use of contact isolation: experience from a three-year period.

Authors:  A Kola; M Holst; I F Chaberny; S Ziesing; S Suerbaum; P Gastmeier
Journal:  J Hosp Infect       Date:  2007-03-12       Impact factor: 3.926

7.  Incidence, risk factors, and outcomes of Klebsiella pneumoniae bacteremia.

Authors:  Bonnie L Meatherall; Daniel Gregson; Terry Ross; Johann D D Pitout; Kevin B Laupland
Journal:  Am J Med       Date:  2009-09       Impact factor: 4.965

8.  Multilocus sequence typing of IncI1 plasmids carrying extended-spectrum beta-lactamases in Escherichia coli and Salmonella of human and animal origin.

Authors:  Aurora García-Fernández; Giuseppina Chiaretto; Alessia Bertini; Laura Villa; Daniela Fortini; Antonia Ricci; Alessandra Carattoli
Journal:  J Antimicrob Chemother       Date:  2008-03-26       Impact factor: 5.790

Review 9.  Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors.

Authors:  R Podschun; U Ullmann
Journal:  Clin Microbiol Rev       Date:  1998-10       Impact factor: 26.132

Review 10.  Global spread of Carbapenemase-producing Enterobacteriaceae.

Authors:  Patrice Nordmann; Thierry Naas; Laurent Poirel
Journal:  Emerg Infect Dis       Date:  2011-10       Impact factor: 6.883
View more
  16 in total

1.  Highly Tigecycline-Resistant Klebsiella pneumoniae Sequence Type 11 (ST11) and ST147 Isolates from Companion Animals.

Authors:  Cristina M Ovejero; Jose Antonio Escudero; Daniel Thomas-Lopez; Andreas Hoefer; Gabriel Moyano; Natalia Montero; Carmen Martin-Espada; Bruno Gonzalez-Zorn
Journal:  Antimicrob Agents Chemother       Date:  2017-05-24       Impact factor: 5.191

2.  First Clinical Case of In Vivo Acquisition of DHA-1 Plasmid-Mediated AmpC in a Salmonella enterica subsp. enterica Isolate.

Authors:  Mathieu Clément; Peter M Keller; Odette J Bernasconi; Guido Stirnimann; Pascal M Frey; Guido V Bloemberg; Parham Sendi; Andrea Endimiani
Journal:  Antimicrob Agents Chemother       Date:  2019-09-23       Impact factor: 5.191

3.  Biosafety considerations and risk reduction strategy for a new veterinary faculty building and teaching hospital in Sweden.

Authors:  Martin Wierup; Ulrika Allard Bengtsson; Ivar Vågsholm
Journal:  Infect Ecol Epidemiol       Date:  2020-06-04

4.  Outbreak of NDM-1-Producing Klebsiella pneumoniae in a Dutch Hospital, with Interspecies Transfer of the Resistance Plasmid and Unexpected Occurrence in Unrelated Health Care Centers.

Authors:  Thijs Bosch; Suzanne P M Lutgens; Mirjam H A Hermans; Peter C Wever; Peter M Schneeberger; Nicole H M Renders; Alexander C A P Leenders; Jan A J W Kluytmans; Annelot Schoffelen; Daan Notermans; Sandra Witteveen; Erik Bathoorn; Leo M Schouls
Journal:  J Clin Microbiol       Date:  2017-05-17       Impact factor: 5.948

5.  Detection of IncN-pST15 one-health plasmid harbouring blaKPC-2 in a hypermucoviscous Klebsiella pneumoniae CG258 isolated from an infected dog, Brazil.

Authors:  Fábio P Sellera; Bruna Fuga; Herrison Fontana; Fernanda Esposito; Brenda Cardoso; Sibele Konno; Carla Berl; Mariana H Cappellanes; Marcia Cortez; Marcelo Ikeda; César M de Souza; Louise Cerdeira; Nilton Lincopan
Journal:  Transbound Emerg Dis       Date:  2021-02-21       Impact factor: 4.521

6.  High Prevalence of Extended-Spectrum β-Lactamase Producing Enterobacteriaceae Among Clinical Isolates From Cats and Dogs Admitted to a Veterinary Hospital in Switzerland.

Authors:  Anna Lena Zogg; Sabrina Simmen; Katrin Zurfluh; Roger Stephan; Sarah N Schmitt; Magdalena Nüesch-Inderbinen
Journal:  Front Vet Sci       Date:  2018-03-27

7.  Shedding of OXA-181 carbapenemase-producing Escherichia coli from companion animals after hospitalisation in Switzerland: an outbreak in 2018.

Authors:  Aurélien Nigg; Michael Brilhante; Valentina Dazio; Mathieu Clément; Alexandra Collaud; Stefanie Gobeli Brawand; Barbara Willi; Andrea Endimiani; Simone Schuller; Vincent Perreten
Journal:  Euro Surveill       Date:  2019-09

8.  Characterization of ESBL- and AmpC-Producing and Fluoroquinolone-Resistant Enterobacteriaceae Isolated from Mouflons (Ovis orientalis musimon) in Austria and Germany.

Authors:  Igor Loncaric; Christoph Beiglböck; Andrea T Feßler; Annika Posautz; Renate Rosengarten; Chris Walzer; Ralf Ehricht; Stefan Monecke; Stefan Schwarz; Joachim Spergser; Anna Kübber-Heiss
Journal:  PLoS One       Date:  2016-05-18       Impact factor: 3.240

9.  Phenotypic and Molecular Characterization of Antimicrobial Resistance in Klebsiella spp. Isolates from Companion Animals in Japan: Clonal Dissemination of Multidrug-Resistant Extended-Spectrum β-Lactamase-Producing Klebsiella pneumoniae.

Authors:  Kazuki Harada; Takae Shimizu; Yujiro Mukai; Ken Kuwajima; Tomomi Sato; Masaru Usui; Yutaka Tamura; Yui Kimura; Tadashi Miyamoto; Yuzo Tsuyuki; Asami Ohki; Yasushi Kataoka
Journal:  Front Microbiol       Date:  2016-06-29       Impact factor: 5.640

10.  Veterinary Hospital Dissemination of CTX-M-15 Extended-Spectrum Beta-Lactamase-Producing Escherichia coli ST410 in the United Kingdom.

Authors:  Dorina Timofte; Iuliana Elena Maciuca; Nicola J Williams; Andrew Wattret; Vanessa Schmidt
Journal:  Microb Drug Resist       Date:  2016-06-17       Impact factor: 3.431
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.